Maintenance on extended-release naltrexone is associated with reduced injection opioid use among justice-involved persons with opioid use disorder.

Audun J LierNikhil SevalBrent Vander WykAngela Di PaolaSandra A Springer

Published in: Journal of substance abuse treatment (2022)

Injection opioid use was low during incarceration and remained low post-release in this justice-involved population. Retention on XR-NTX was associated with reduced intravenous opioid use, which has important implications for reducing transmission of HIV and HCV.

Keyphrases

hepatitis c virus
human immunodeficiency virus
antiretroviral therapy
ultrasound guided
hiv infected
hiv positive
chronic pain
mental illness
pain management
high dose
hiv aids
hiv testing